Core Laboratories Inc.
US ˙ NYSE ˙ US21867A1051

SecurityCLB / Core Laboratories Inc.
InstitutionSignaturefd, Llc
Latest Disclosed Ownership1,444 shares
Latest Disclosed Value $ 24,245
Signaturefd, Llc ownership in CLB / Core Laboratories Inc.

On April 7, 2026 - Signaturefd, Llc filed a 13F-HR form disclosing ownership of 1,444 shares of Core Laboratories Inc. (US:CLB) valued at $24,245 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 1,444 shares of Core Laboratories Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $18,671 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F CORE LABORATORIES COM 21867A105 1,444 0 0.00 24 4.35 0.0004
2026-01-20 2025-12-31 13F CORE LABORATORIES COM 21867A105 1,444 0 0.00 23 35.29 0.0004
2025-10-21 2025-09-30 13F CORE LABORATORIES COM 21867A105 1,444 22 1.55 18 6.25 0.0003
2025-07-16 2025-06-30 13F CORE LABORATORIES COM 21867A105 1,422 -2,571 -64.39 16 -72.88 0.0003
2025-05-02 2025-03-31 13F CORE LABORATORIES COM 21867A105 3,993 -2,418 -37.72 60 -46.36 0.0011
2025-02-10 2024-12-31 13F CORE LABORATORIES COM 21867A105 6,411 -7 -0.11 111 -6.78 0.0021
2024-10-21 2024-09-30 13F CORE LABORATORIES COM 21867A105 6,418 -358 -5.28 119 -13.87 0.0023
2024-07-29 2024-06-30 13F CORE LABORATORIES COM 21867A105 6,776 767 12.76 137 34.31 0.0028
2024-05-03 2024-03-31 13F CORE LABORATORIES COM 21867A105 6,009 4,473 291.21 103 277.78 0.0022
2024-02-01 2023-12-31 13F CORE LABORATORIES COM 21867A105 1,536 377 32.53 27 0.00 0.0006
2023-11-03 2023-09-30 13F CORE LABORATORIES COM 21867A105 1,159 -431 -27.11 28 -25.00 0.0007
2023-08-01 2023-06-30 13F CORE LABORATORIES COM 21867A105 1,590 395 33.05 37 38.46 0.0009
2023-04-28 2023-03-31 13F CORE LABORATORIES N V COM N22717107 1,195 58 5.10 26 13.04 0.0007
2023-01-30 2022-12-31 13F CORE LABORATORIES N V COM N22717107 1,137 353 45.03 23 109.09 0.0007
2022-11-08 2022-09-30 13F CORE LABORATORIES N V COM N22717107 784 161 25.84 11 -8.33 0.0004
2022-08-10 2022-06-30 13F CORE LABORATORIES N V COM N22717107 623 -123 -16.49 12 -50.00 0.0004
2022-05-02 2022-03-31 13F CORE LABORATORIES N V COM N22717107 746 -2 -0.27 24 41.18 0.0007
2022-01-25 2021-12-31 13F CORE LABORATORIES N V COM N22717107 748 11 1.49 17 -15.00 0.0005
2021-10-28 2021-09-30 13F CORE LABORATORIES N V COM N22717107 737 43 6.20 20 -25.93 0.0007
2021-07-26 2021-06-30 13F CORE LABORATORIES N V COM N22717107 694 0 0.00 27 35.00 0.0011
2021-04-30 2021-03-31 13F CORE LABORATORIES N V COM N22717107 694 0 0.00 20 11.11 0.0009
2021-02-11 2020-12-31 13F CORE LABORATORIES N V COM N22717107 694 188 37.15 18 125.00 0.0008
2020-11-03 2020-09-30 13F CORE LABORATORIES N V COM N22717107 506 24 4.98 8 -20.00 0.0004
2020-07-30 2020-06-30 13F CORE LABORATORIES N V COM N22717107 482 -352 -42.21 10 11.11 0.0006
2020-04-23 2020-03-31 13F CORE LABORATORIES N V COM N22717107 834 650 353.26 9 28.57 0.0008
2020-02-05 2019-12-31 13F CORE LABORATORIES N V COM N22717107 184 20 12.20 7 -12.50 0.0005
2019-10-16 2019-09-30 13F CORE LABORATORIES N V COM N22717107 164 -95 -36.68 8 -42.86 0.0007
2019-07-31 2019-06-30 13F CORE LABORATORIES N V COM N22717107 259 -25 -8.80 14 -30.00 0.0012
2019-05-09 2019-03-31 13F CORE LABORATORIES N V COM N22717107 284 -13 -4.38 20 11.11 0.0017
2019-02-13 2018-12-31 13F CORE LABORATORIES N V COM N22717107 297 -521 -63.69 18 -81.05 0.0017
2018-11-14 2018-09-30 13F CORE LABORATORIES N V COM N22717107 818 7 0.86 95 -6.86 0.0097
2018-08-14 2018-06-30 13F CORE LABORATORIES N V COM N22717107 811 650 403.73 102 500.00 0.0114
2018-05-08 2018-03-31 13F CORE LABORATORIES N V COM N22717107 161 161 17 0.0020
2017-02-14 2016-12-31 13F CORE LABORATORIES N V COM N22717107 0 -18 -100.00 0 -100.00
2016-11-14 2016-09-30 13F CORE LABORATORIES N V COM N22717107 18 7 63.64 2 100.00 0.0003
2016-07-29 2016-06-30 13F CORE LABORATORIES N V COM N22717107 11 0 0.00 1 0.00 0.0001
2016-05-12 2016-03-31 13F CORE LABORATORIES N V COM N22717107 11 0 0.00 1 0.00 0.0002
2016-01-22 2015-12-31 13F CORE LABORATORIES N V COM N22717107 11 0 0.00 1 0.00 0.0002
2015-10-23 2015-09-30 13F CORE LABORATORIES N V COM N22717107 11 11 1 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.